Physician
Gastroenterology
Dr. Raymond S. Koff, MD
|
|
Give Review
Raymond S. Koff is an expert in the field of Gastroenterology. He went to Albert Einstein College of Medicine of Yeshiva University. He over the years received 1 awards: "Fellow (FACG)". Raymond Koff is a published MD as well. He has 98 publications published. The latest was: Pretreatment evaluation of chronic hepatitis C: risks, benefits, and costs.
Publications
- Report of an international workshop: Roadmap for management of patients receiving oral therapy for chronic hepatitis B.
- Fulminant hepatitis A: Disappearing, but not soon enough.
- Osteoarthritis of the knee.
- The therapeutic use of acetaminophen in patients with liver disease.
- An economic assessment of pre-vaccination screening for hepatitis A and B.
- Regional variation in the cost effectiveness of childhood hepatitis A immunization.
- Cholestatic hepatitis induced by Epstein-Barr virus infection in an adult.
- Prevention of Viral Hepatitis.
- Re: Arguedas et al.--Hepatitis A prevention analysis.
- Hepatitis A, hepatitis B, and combination hepatitis vaccines for immunoprophylaxis: an update.
- The cost-effectiveness of vaccinating chronic hepatitis C patients against hepatitis A.
- Hepatitis vaccines: recent advances.
- Iron and HFE or TfR1 mutations as comorbid factors for development and progression of chronic hepatitis C.
- Feinstone SM, Kapikian AZ, Purcell RH. Hepatitis A: detection by immune electron microscopy of a virus like antigen associated with acute illness [Science 1973;182:102...
- Immunogenicity of hepatitis B vaccines: implications of immune memory.
- Gastroenterologist specialist care and care provided by generalists--an evaluation of effectiveness and efficiency.
- Phlebotomy improves therapeutic response to interferon in patients with chronic hepatitis C: a meta-analysis of six prospective randomized controlled trials.
- Review article: vaccination and viral hepatitis - current status and future prospects.
- Prevention of hepatitis C virus infection.
- Cost-effectiveness of combined interferon and ribavirin versus interferon alone.
- Risks associated with hepatitis A and hepatitis B in patients with hepatitis C.
- Terbinafine-induced hepatitis and pancytopenia.
- Cost-effectiveness of interferon-alpha 2b treatment for hepatitis B e antigen-positive chronic hepatitis B.
- Gastroenterology and hepatology.
- Herbal hepatotoxicity. Revisiting a dangerous alternative.
- Seroepidemiology of hepatitis A in the United States.
- Discussion: who should receive hepatitis A vaccine? A strategy for controlling hepatitis A in the United States.
- Immunogenicity of hepatitis B vaccines.
- Problem hepatitis viruses: the mutants.
- Idiopathic autoimmune chronic hepatitis triggered by hepatitis A.
- Hepatitis B today: clinical and diagnostic overview.
- A redoubtable obstacle to a hepatitis C vaccine.
- Immunization with naked DNA: a sexy technique.
- Efficacy of hepatitis B immune serum globulin after accidental exposure. Preliminary report of the Veterans Administration Cooperative Study.
- Successful intravenous cholecystocholangiography in the jaundiced patient using meglumine iodoxamate (Cholovue).
- D-galactosamine hepatotoxicity. IV. Further studies of the pathogenesis of fatty liver.
- Lactic acidosis in oat cell carcinoma with extensive hepatic metastases.
- Neuropsychological dysfunction in acute viral hepatitis.
- Severe intrahepatic cholestasis in primary amyloidosis: a report of four cases and a review of the literature.
- Ascites following renal transplantation.
- Type B hepatitis after needle-stick exposure: prevention with hepatitis B immune globulin. Final report of the Veterans Administration Cooperative Study.
- Carcinoembryonic antigen levels in benign and malignant pleural effusions.
- Carcinoembryonic antigen assay of ascites and detection of malignancy.
- Peliosis hepatis in hematologic disease. Report of two cases.
- [Salicylate hepatitis].
- Contagiousness of acute hepatitis B. Secondary attack rates in household contacts.
- Serum lipids, insulin, and glucagon after portacaval shunt in cirrhosis.
- Salicylate hepatitis.
- Health hazards of bivalve-mollusk ingestion.
- Thorotrast and the liver: a reminder.
- Failure to detect hepatitis B surface antigen (HBsAg) in certified shellfish from New England.
- Modification of the hepatotoxicity of D-galactosamine in the rat by cycloheximide.
- Fulminant hepatitis and lymphocyte sensitization due to propylthiouracil.
- The low efficiency of maternal-neonatal transmission of hepatitis C virus: how certain are we?
- Clinical manifestations and diagnosis of hepatitis A virus infection.
- Hepatocellular carcinoma in transgenic mice: a consequence of continued expression of the HBx gene?
- Prenylation of the large hepatitis delta virus antigen: a target for antiviral therapy.
- Replication of the hepatitis D virus genome without hepatitis B virus.
- Rapid induction of gluconeogenesis during fasting.
- Long-term hepatic memory for hypersensitivity to nitrofurantoin.
- Intravenous interferon-beta in chronic hepatitis B: promises.
- Nonsteroidal anti-inflammatory drug use in relation to major upper gastrointestinal bleeding.
- Preventing hepatitis A infections in travelers to endemic areas.
- Critical issues surrounding hepatitis B vaccination for adolescents: a roundtable.
- Therapy in chronic hepatitis C: say goodbye to the 6-month interferon regimen.
- Risk of aspirin-associated major upper-gastrointestinal bleeding with enteric-coated or buffered product.
- Treatment of chronic hepatitis C with interferon alfa-n3: a multicenter, randomized, open-label trial.
- Therapy of hepatitis C: cost-effectiveness analysis.
- Interferon-alpha for chronic hepatitis C: reducing the uncertainties.
- Should health care workers exposed to hepatitis C routinely receive hepatitis A vaccine?
- Safety and immunogenicity of hepatitis A vaccine in patients with chronic liver disease.
- Clinical aspects of upper gastrointestinal bleeding associated with the use of nonsteroidal antiinflammatory drugs.
- Chronic hepatitis C: early intervention.
- Impaired health-related quality of life in chronic hepatitis C: the how, but not the why.
- Pretreatment evaluation of chronic hepatitis C: risks, benefits, and costs.
- The case for routine childhood vaccination against hepatitis A.
- A phase I/II study of recombinant human interleukin-12 in patients with chronic hepatitis C.
- Interferon-alpha in hepatitis C.
- Advances in the treatment of chronic viral hepatitis.
- The risk of acute major upper gastrointestinal bleeding among users of aspirin and ibuprofen at various levels of alcohol consumption.
- Cost-effectiveness of treatment for chronic hepatitis C.
- Hepatitis B school-based vaccination programmes in the USA: a model for hepatitis A and B.
- Outcomes and costs of care in hepatitis C: combination therapy scores again.
- Isolated elevation of serum alkaline phosphatase level in an uncomplicated pregnancy: a case report.
- Cost-effectiveness of hepatitis A vaccination in patients with chronic hepatitis C.
- Combination therapy in naive patients with chronic hepatitis C: more value for the money.
- When and how to screen for liver disease.
- Watchful waiting with periodic liver biopsy versus immediate empirical therapy for histologically mild chronic hepatitis C. A cost-effectiveness analysis.
- Diagnosis and monitoring of hepatic injury. I. Performance characteristics of laboratory tests.
- Diagnosis and monitoring of hepatic injury. II. Recommendations for use of laboratory tests in screening, diagnosis, and monitoring.
- Anti-HCV screening of blood donors: the impact in Spain.
- Acute and chronic giant cell hepatitis: a paramyxovirus infection?
- Transforming growth factors in human chronic hepatitis and cirrhosis: correlations with fibrogenesis and hepatic regeneration.
- Interferon in clinically stable, replicative chronic hepatitis B: good news for some.
- Interferon treatment of chronic non-A, non-B (HCV) hepatitis: the saga continues.
- And now, the molecular cloning of the hepatitis E virus.
- Effect of differentiation and cell density on glycosphingolipid class and molecular species composition of mouse neuroblastoma NB2a cells.
Schools
Albert Einstein College of Medicine of Yeshiva University
Barnes Hospital
Barnes Jewish Hospital
Massachusetts General Hospital
Doctors Specialties
- Internal Medicine
- Gastroenterology
Accepted Insurances
Awards
- Fellow (FACG)
Education
-
Massachusetts General Hospital -
Washington University - Barnes-Jewish Hospital -
Albert Einstein College of Medicine of Yeshiva University
Hospital
-
MetroWest Medical Center
Helpful Reviews
Similar Doctors
|
|
Dr. John H. Walsh, MD |
|
|
Dr. Laurie E. Katzman, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ronald M. Katz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John M. Kauffman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Frederick L. Makrauer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Linda S. Lee, MD |
|
|
Dr. Laura E. Smith, MD |
|
|
Dr. Karen M. Sherritt, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jennifer H. Lee, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Deborah M. Pressman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lori A. Farnan, MD
This Doctor is OpenDoctor Recommended.
|